Trump Drug Czar Nominee Calls Cannabis Bipartisan but Keeps All Scheduling Options Open

The pick for the next White House drug czar, Sara Carter, recently shared some promising thoughts on the future of cannabis during her Senate confirmation hearing. When questioned by Senator Cory Booker, Carter acknowledged that marijuana reform has become a bipartisan issue and stated the administration is keeping all options open regarding the pending move to Schedule III. She expressed a commitment to following the data and research, even highlighting past support for medical access for veterans.

This is a massive development for the community because it suggests the new administration might actually follow through on rescheduling rather than reverting to old-school prohibition tactics. For everyday tokers, moving to Schedule III would finally acknowledge the medical benefits of the plant on a federal level and tear down the research barriers that have held the industry back for decades. While we aren't at full legalization yet, having a drug czar who views cannabis through a lens of research and bipartisan cooperation is a breath of fresh air for everyone waiting on federal progress.